L03AB10 • peginterferon alfa 2B • Antineoplastic and immunomodulating agents | Immunostimulants | Interferons
Peginterferon alfa-2b is a medication used for the treatment of chronic hepatitis B and C, as well as certain types of cancer, such as malignant melanoma. It is a pegylated form of interferon that stimulates the immune system to fight viral infections and cancer cells.
The medication is administered as a subcutaneous injection, as directed by your doctor. It is important to follow the administration schedule and monitor liver function and other blood tests during treatment.
Side effects may include fatigue, flu-like symptoms, depression, nausea, or weight loss. In rare cases, severe reactions such as liver function impairment or autoimmune disorders may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of peginterferon alfa-2b.
Substance: peginterferon alfa 2B
Date of last drug list: 01-07-2013
Commercial code: W52112007
Concentration: 120mcg / 0.5ml
Pharmaceutical form: powder+solution for injection
Quantity: 1
Product type: original
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.